Ongoing research aims to better understand the genetic basis of MODY 3 and develop more targeted therapies. Studies are exploring the effectiveness of newer medications and potential gene therapies. Researchers are also investigating the long-term outcomes of individuals diagnosed in childhood to improve management strategies.
